What is bovine serum albumin?

Bovine serum albumin (BSA) is a protein derived from cow blood that's widely used in laboratory research, diagnostics, and biotechnology. It serves as a stabilizer, carrier protein, and standard in various scientific applications, including medical testing and vaccine production.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Bovine Serum Albumin

Bovine serum albumin, commonly abbreviated as BSA, is one of the most extensively used proteins in research laboratories and biotechnology applications worldwide. This versatile protein is extracted from the blood serum of cows and has become an indispensable tool in scientific research, medical diagnostics, and pharmaceutical development.

BSA belongs to the albumin family of proteins, which are the most abundant proteins found in blood plasma. In cows, as in humans, albumin serves crucial physiological functions, including maintaining blood pressure, transporting various molecules throughout the body, and acting as an antioxidant. The bovine version shares approximately 76% sequence similarity with human serum albumin, making it an excellent model protein for various applications.

Chemical Structure and Properties

BSA is a large, globular protein with a molecular weight of approximately 66.5 kilodaltons (kDa). Its structure consists of 583 amino acids arranged in a single polypeptide chain that folds into three homologous domains. Each domain contains two subdomains that form a heart-shaped molecule when viewed from certain angles.

BSA vs Human Serum Albumin Comparison

Selection between BSA and HSA depends on specific application requirements, budget, and regulatory considerations.
PropertyBSAHSAKey Differences
SourceSourceBovine bloodHuman blood/plasmaSpecies origin affects immunogenicity
Molecular WeightMolecular Weight66.5 kDa66.5 kDaNearly identical size
Sequence SimilaritySequence Similarity76% to HSA100% (reference)May cause immune reactions in humans
CostCostLow ($50-200/kg)High ($500-2000/kg)10-40x price difference
Primary UsePrimary UseResearch, diagnosticsTherapeutics, researchApplication-specific selection
Regulatory StatusRegulatory StatusResearch gradePharmaceutical gradeHSA required for human therapeutics

Selection between BSA and HSA depends on specific application requirements, budget, and regulatory considerations.

Key Physical Properties

  • Molecular weight: 66,463 Da
  • Isoelectric point (pI): 4.7-5.3
  • Solubility: Highly soluble in water (up to 40% w/v)
  • Stability: Stable at pH 4-9 and temperatures up to 60°C
  • Structure: 17 disulfide bonds providing structural stability

The protein contains multiple binding sites that allow it to interact with a wide variety of molecules, including fatty acids, hormones, drugs, and metal ions. This binding capacity is one of the primary reasons BSA is so valuable in research applications.

Production and Purification Methods

The production of BSA begins with the collection of bovine blood from cattle at slaughterhouses. The blood is processed to separate the serum from cellular components, and then various purification methods are employed to isolate the albumin protein.

Common Purification Techniques

  1. Cold ethanol fractionation (Cohn process): The traditional method using ethanol precipitation at low temperatures
  2. Heat shock treatment: Exploiting BSA's thermal stability to denature contaminants
  3. Chromatographic methods: Including ion exchange, gel filtration, and affinity chromatography
  4. Crystallization: Producing highly pure BSA through repeated crystallization steps

The purity of BSA is crucial for its applications, with different grades available depending on the intended use. Research-grade BSA typically has a purity of 96-99%, while specialized applications may require even higher purity levels.

Applications in Research and Diagnostics

BSA's versatility makes it invaluable across numerous scientific disciplines. Its stability, availability, and well-characterized properties have established it as a standard reagent in laboratories worldwide.

Laboratory Research Applications

  • Protein standard: Used as a reference in protein concentration assays like Bradford and BCA assays
  • Blocking agent: Prevents non-specific binding in immunoassays, Western blots, and ELISA
  • Stabilizer: Protects enzymes and other proteins during storage and reactions
  • Cell culture supplement: Provides nutrients and growth factors for cultured cells
  • Carrier protein: Facilitates the delivery of small molecules and drugs in experiments

In medical diagnostics, BSA plays a critical role in many blood tests and diagnostic assays. It's used to stabilize reagents, calibrate instruments, and ensure accurate results in clinical laboratories. Understanding how proteins like BSA function in diagnostic tests can help you better appreciate the complexity of modern blood testing. If you're interested in monitoring your own health biomarkers through advanced blood testing, comprehensive programs can provide valuable insights into your metabolic and overall health status.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Role in Biotechnology and Pharmaceutical Development

The biotechnology industry relies heavily on BSA for various applications in drug development, vaccine production, and therapeutic protein manufacturing. Its ability to stabilize other proteins and prevent aggregation makes it particularly valuable in formulating biopharmaceuticals.

Pharmaceutical Applications

BSA serves multiple functions in pharmaceutical development, including as an excipient in drug formulations, a stabilizer for vaccines during storage and transport, and a component in diagnostic test kits. Many COVID-19 diagnostic tests, for example, utilize BSA to ensure test accuracy and stability.

In vaccine development, BSA helps maintain the stability of viral antigens and prevents their degradation during storage. This is particularly important for vaccines that need to be transported to remote locations or stored for extended periods.

BSA vs Human Serum Albumin

While BSA and human serum albumin (HSA) share many similarities, there are important differences that affect their use in various applications. Understanding these differences is crucial for researchers and clinicians when selecting the appropriate albumin for their specific needs.

The choice between BSA and HSA often depends on the specific application. BSA is preferred for general research due to its lower cost and availability, while HSA is essential for human therapeutic applications and certain specialized research involving human systems.

Safety Considerations and Quality Standards

Given BSA's animal origin, safety considerations are paramount, particularly regarding the potential transmission of bovine spongiform encephalopathy (BSE) or other pathogens. Manufacturers must adhere to strict quality control measures and source materials from BSE-free countries.

  • Source certification: BSA must come from countries with negligible BSE risk
  • Processing controls: Heat treatment and other methods to inactivate potential pathogens
  • Quality testing: Regular testing for contaminants, endotoxins, and purity
  • Regulatory compliance: Adherence to FDA, EMA, and other regulatory guidelines
  • Traceability: Complete documentation of source materials and processing steps

For applications in human diagnostics or therapeutics, additional safety measures may include viral inactivation steps and extensive testing for adventitious agents.

Environmental and Ethical Considerations

As awareness of environmental sustainability and animal welfare grows, the production and use of BSA face increasing scrutiny. The protein is a byproduct of the meat industry, which raises questions about sustainability and ethical sourcing.

Researchers and companies are exploring alternatives to traditional BSA, including recombinant albumin produced in yeast or bacteria, plant-based protein alternatives, and synthetic peptides that can mimic BSA's functions. These alternatives may offer advantages in terms of consistency, safety, and ethical considerations, though they often come at a higher cost.

Future Perspectives and Innovations

The future of BSA and albumin proteins in research and medicine continues to evolve. Advances in protein engineering are creating modified versions of albumin with enhanced properties, such as extended half-life for drug delivery applications or improved binding characteristics for specific molecules.

Nanotechnology applications are also emerging, with BSA being used to create nanoparticles for targeted drug delivery and imaging applications. These BSA-based nanocarriers can encapsulate drugs and deliver them specifically to diseased tissues, potentially improving treatment efficacy while reducing side effects.

As personalized medicine advances, understanding proteins like albumin becomes increasingly important for interpreting individual health data. Regular monitoring of your own albumin levels, along with other key biomarkers, can provide insights into liver function, nutritional status, and overall health. For those interested in tracking their albumin levels and other important health markers, comprehensive testing programs offer convenient at-home options with professional analysis.

The Essential Role of BSA in Modern Science

Bovine serum albumin remains one of the most important proteins in scientific research and biotechnology. Its unique combination of stability, versatility, and well-characterized properties has made it indispensable in applications ranging from basic research to advanced therapeutics. As science continues to advance, BSA will likely remain a crucial tool while also inspiring the development of new alternatives and applications.

Whether you're a researcher using BSA in your experiments, a healthcare professional relying on BSA-containing diagnostics, or simply someone interested in understanding the science behind modern medicine, appreciating the role of this remarkable protein helps illuminate the complexity and ingenuity of biotechnology. As we continue to develop new technologies and treatments, proteins like BSA will remain at the forefront of scientific innovation, enabling discoveries that improve human health and advance our understanding of biological systems.

For those interested in understanding their own protein levels and overall health status, modern blood testing has made it easier than ever to gain insights into your body's functioning. You can even upload existing blood test results for a comprehensive analysis at SiPhox Health's free upload service, which provides personalized insights and recommendations based on your unique biomarker profile.

References

  1. Majorek, K. A., Porebski, P. J., Dayal, A., Zimmerman, M. D., Jablonska, K., Stewart, A. J., Chruszcz, M., & Minor, W. (2012). Structural and immunologic characterization of bovine, horse, and rabbit serum albumins. Molecular Immunology, 52(3-4), 174-182.[Link][PubMed][DOI]
  2. Francis, G. L. (2010). Albumin and mammalian cell culture: implications for biotechnology applications. Cytotechnology, 62(1), 1-16.[Link][PubMed][DOI]
  3. Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012). Human serum albumin: from bench to bedside. Molecular Aspects of Medicine, 33(3), 209-290.[Link][PubMed][DOI]
  4. Gelamo, E. L., Silva, C. H., Imasato, H., & Tabak, M. (2002). Interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants: spectroscopy and modelling. Biochimica et Biophysica Acta, 1594(1), 84-99.[Link][PubMed][DOI]
  5. Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012). Albumin-based nanoparticles as potential controlled release drug delivery systems. Journal of Controlled Release, 157(2), 168-182.[Link][PubMed][DOI]
  6. Rosenoer, V. M., Oratz, M., & Rothschild, M. A. (Eds.). (2014). Albumin: Structure, Function and Uses. Pergamon Press.[Link]

Was this article helpful?

Frequently Asked Questions

How can I test my albumin at home?

You can test your albumin at home with SiPhox Health's Core Health Program, which offers albumin testing through the Metabolic+ expansion. This CLIA-certified program provides lab-quality results from the comfort of your home, along with personalized insights about your liver function and nutritional status.

What is the difference between BSA and human albumin?

BSA comes from cow blood and shares about 76% similarity with human albumin. While both proteins have similar functions, BSA is primarily used in research and diagnostics due to its lower cost and availability, whereas human albumin is required for therapeutic applications in humans.

Why is BSA so commonly used in laboratories?

BSA is widely used because it's stable, affordable, well-characterized, and versatile. It serves as a protein standard, blocking agent, stabilizer, and carrier protein in countless research applications, making it one of the most important reagents in modern laboratories.

Is BSA safe to use in medical applications?

BSA used in medical applications undergoes strict quality control and safety testing. It must come from BSE-free countries and undergo processing to eliminate potential pathogens. However, for human therapeutic use, human serum albumin is typically preferred.

What are the main applications of BSA in diagnostics?

In diagnostics, BSA stabilizes reagents, prevents non-specific binding in immunoassays, serves as a calibration standard, and helps maintain the accuracy of blood tests and other diagnostic assays. It's an essential component in many COVID-19 tests, ELISA assays, and clinical chemistry analyzers.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details